Vote Now
Home | News | Events | Press | Contact  

About UseNewsletterMessage BoardsAction CenterAdvocateWalk to End Alzheimer’sShopDonate

Find your chapter:

search by state

In My Community

Weekly e-news

We will not share your information.

Care & Conquer St. Louis Session
Text Size controlsNormal font sizeMedium font sizeLarge font size



St. Louis
Thursday, Nov. 13 | 6-8:30 p.m.
Registration begins at 5:30 p.m.
Hilton St. Louis Frontenac
1335 S Lindbergh Blvd | St. Louis, MO 63131

Tickets are $10 per person
*Some scholarships are available. Please call the Alzheimer’s Association at 800.272.3900 for more information. 

For our largest event, we are excited to host Dr. John Morris and Dr. Eric Reiman (invited). Both of these physicians are experts in Alzheimer’s disease and are internationally recognized for their research. This event will focus on research concerning early detection and diagnosis and provide important information for the general community. The speakers will be followed by a presentation of complimentary caregiver resources. Hot appetizers and a cash bar will be available. 

Rodger Riney, CEO of Scottrade and Alzheimer's Association St. Louis Chapter Board Memer will give opening remarks.

Eric M. Reiman, M.D. (invited)

Executive Director, Banner Alzheimer’s Institute
Chief Executive Officer, Banner Research
Clinical Director, Neurogenomics Division, Translational Genomics Research Institute
Professor of Psychiatry
Director, Arizona Alzheimer’s Consortium

Dr. Reiman’s research interests include brain imaging, genomics, the unusually early detection and tracking of Alzheimer’s disease (AD), and the accelerated evaluation of AD prevention therapies. He is an author of more than 250 publications, a principal investigator of several NIH grants, director of the NIA-sponsored Arizona AD Center, and a recipient of the 2013 Potamkin Prize. He and his colleagues have used imaging methods to detect and track preclinical AD in persons at differential genetic risk, they have established the Alzheimer’s Prevention Initiative (API) to help in the accelerated evaluation of promising preclinical AD treatments, and they have developed several research methods and strategies to help in this endeavor.

John Morris, M.D.

Harvey A. and Dorismae Hacker Friedman Professor of Neurology
Professor, Pathology and Immunology
Director, Center for Aging
Director, Memory and Aging Project
Director, Knight Alzheimer's Disease Research Center

Dr. Morris is the principal investigator for four multicomponent research grants, awarded by the National Institute on Aging (NIA), to study various aspects of Alzheimer’s disease. These grants include the Knight Alzheimer Disease Research Center, which Dr. Morris directs, two program projects, “Healthy Aging and Senile Dementia” and “Antecedent Biomarkers for AD: The Adult Children Study”; and a cooperative agreement that establishes an international consortium of leading academic centers, “The Dominantly Inherited Alzheimer Network” (DIAN). Dr. Morris directs all of these programs with the overarching goal of identifying Alzheimer disease in its earliest stages, prior to the onset of any symptoms, so that therapies can be initiated to prevent the occurrence of Alzheimer’s dementia.


Sponsored by:



Join or start a team today.

Find a Walk

Washington Alaska Texas Washington Oregon California Idaho Nevada Arizona Utah Montana Wyoming Colorado New Mexico Oklahoma Kansas Nebraska South Dakota North Dakota Minnesota Iowa Missouri Arkansas Louisiana Mississippi Illinois Wisconsin Michigan Indiana Kentucky Tennessee Alabama Florida Georgia South Carolina North Carolina Virginia West Virginia Ohio Maine Pennsylvania New York Vermont New Hampshire Massachusetts Rhode Island Connecticut New Jersey onClick= Delaware Maryland Hawaii Vermont New Hampshire Massachusetts Rhode Island Connecticut New Jersey Delaware Maryland Washington D.C.
Alzheimer's Association

Our vision is a world without Alzheimer's
Formed in 1980, the Alzheimer's Association is the world's leading voluntary health organization in Alzheimer's care, support and research.